BioCatalystWatch
DFTXWorkspace / DFTX / OverviewCompany library
Definium Therapeutics, Inc. logo

Definium Therapeutics, Inc.

Definium Therapeutics, Inc. (DFTX)

Website

Price
Market cap
Next catalystExpected 2026DT120 ODT — programme regulatory guidance · Regulatory meetingCompany presentation ↗
Cash

Chart & Events

Candle interval

Core Clinical

DT120 ODT

5-HT2A receptor

PreINDP1P2FilingApproved
Upcoming / outlook

DT120 ODT

5-HT2A receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

DT120 ODT

5-HT2A receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

DT402

PreINDP1P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

DT402

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

DT120 ODT

5-HT2A receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

DT120 ODT

5-HT2A receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

DT402

PreINDP1P3FilingApproved
Upcoming / outlook

DT120 ODT

5-HT2A receptor

PreINDP1P2FilingApproved
Upcoming / outlook

Other pipelines

5-HT2A receptor

PreINDP1P2P3FilingApproved

18-MC

α3β4 nicotinic acetylcholine receptor

PreINDP1P2P3FilingApproved
18-MC

α3β4 nicotinic acetylcholine receptor

PreINDP1P2P3FilingApproved

Partner / License out

DT120 ODT

5-HT2A receptor

PreINDP1P2P3FilingApproved
DT120 ODT

5-HT2A receptor

PreINDP1P2P3FilingApproved

History / paused

DT402

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status
3M

Market Reaction / Supply Context

Market Structure

DFTX PR & News

PR & News

DFTX SEC archive